Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer
Clinical trial NCT04999540 · UNKNOWN
Trial details
- NCT number
- NCT04999540
- Sponsor
- Guangdong Women and Children Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2023-12-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.